Quali-Care Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.20 M
as on 25-06-2024
- Paid Up Capital ₹ 5.00 M
as on 25-06-2024
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 1.71 Cr
as on 25-06-2024
About Quali-Care Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 6.20 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.71 Cr.
Anand Veerapaneni, Lakshmi Chandana, and Surya Veerapaneni serve as directors at the Company.
- CIN/LLPIN
U24239TG1985PLC005955
- Company No.
005955
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Nov 1985
- Date of AGM
30 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationHyderabad, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Quali-Care Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Veerapaneni  | Additional Director | 01-Jan-2010 | Current |
| Lakshmi Chandana | Director | 20-Apr-2013 | Current |
| Surya Veerapaneni | Additional Director | 30-Jan-2010 | Current |
Financial Performance of Quali-Care Pharmaceuticals.
Enhance accessibility to Quali-Care Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Quali-Care Pharmaceuticals?
Unlock access to Quali-Care Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Savan Pharmaceuticals Private LimitedActive 22 years 9 monthsAnand Veerapaneni and Surya Veerapaneni are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 05 Jul 2013 | ₹7.50 M | Open |
Manasa Co - Op. Urban Bank Ltd. Creation Date: 01 Nov 2004 | ₹3.00 M | Open |
Ceat Financial Services Ltd. Creation Date: 30 Sep 1997 | ₹0.19 M | Open |
How Many Employees Work at Quali-Care Pharmaceuticals?
Unlock and access historical data on people associated with Quali-Care Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quali-Care Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quali-Care Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
